Central Adelaide Local Health Network Human Research Ethics Committee

Central Adelaide Local Health Network (CALHN) previously supported two human research ethics committees (HRECs): Royal Adelaide Hospital REC and TQEH/LHM/MH HREC.

As of 1 January 2018, the two HRECs are merged into one committee known as the Central Adelaide Local Health Network Human Research Ethics Committee (CALHN HREC). The CALHN HREC will retain responsibility for monitoring all projects previously approved by the RAH REC and TQEH/LMH/MH HREC.

Prior to commencement of any human research activity in a public health organisation, researchers must obtain ethical approval and governance authorisation.

The Central Adelaide Local Health Network Human Research Ethics Committee (CALHN HREC) is constituted in accordance with the National Health and Medical Research Council (NHMRC) National Statement on Ethical Conduct in Human Research 2007 (updated in 2018), and is accredited under the National Mutual Acceptance Scheme.

The CALHN HREC is responsible for the ethical and scientific review of research proposals including clinical trials and health/medical research projects, and is certified to review applications in the following areas:

  • Clinical trials – Phases I, II, III, IV
  • Clinical research other than clinical trials
  • Population health and/or Public health
  • Qualitative health research
  • Mental health

The committee meets twice each month, and is responsible for ensuring that research conducted by staff and external researchers meets ethical and scientific requirements in accordance with the NHMRC and relevant legislative and policy requirements.

CALHN HREC Chair: Mr Ian Tindall

CALHN HREC Executive Officer

Email: [email protected]
Phone: +61 8 8222 6841 or +61 8 7117 2229

The Queen Elizabeth Hospital
Ground Floor, Basil Hetzel Institute
28 Woodville Road

Please note all submissions to the CALHN HREC (ie greater than low/negligible risk and therefore requiring review by the full Committee) must be made via Research GEMS. Guidelines for submission are available here.

Note: The Research GEMS system does not currently support expedited review applications for low/negligible risk research. Submissions must be made via email.